![]() |
市場調查報告書
商品編碼
2133436
超音波吸引器市場規模、佔有率及趨勢分析 |全球| 2026–2032 | 包括資本設備、配件及其他(3 個類別)Ultrasonic Aspirator Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Capital Equipment, Accessories, and 3 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2025年全球超音波吸引器市場價值約4.4億美元。預計該市場將以3.5%的複合年成長率成長,到2032年達到約5.57億美元。
本報告涵蓋全球超音波吸引器市場的資本設備、一次性探頭、一次性導管、牙科手機和配件。基於截至2022年的歷史數據和截至2032年的預測,本報告對手術數量、銷量、平均售價(ASP)、市場規模、成長率和企業市場占有率進行了定量分析。
腫瘤切除是超音波吸引器市場的主要驅動力。這是因為這些設備能夠選擇性地針對癌變組織,同時保護周邊的神經和血管。這種特性使其在複雜的神經外科手術和血管豐富的解剖區域中尤為有用。市場成長得益於設備約5-7年的穩定更新周期,以及超音波吸引術在非神經外科領域的臨床應用不斷擴大,在這些領域,超音波吸引術在血管器官的解剖結構方面具有顯著優勢。
該市場在其主要市場—神經外科領域已趨於成熟和飽和。幾乎所有進行神經外科手術的機構都已採用超音波吸引器。拓展至鄰近的外科專科,例如一般外科、婦科、消化內科和整形外科,是實現產品在更換週期之外持續成長的主要途徑。尤其值得一提的是,隨著針對不同應用場景的專用針頭設計不斷湧現並得到應用,一次性針頭市場正呈現活躍成長態勢。
市場概覽
超音波吸引器利用高頻振動選擇性地分解和抽吸組織,使外科醫生能夠精準地切除腫瘤和其他目標組織,同時最大限度地減少對鄰近神經、血管和健康組織的損傷。這項功能在神經外科手術中尤其重要,因為在切除腦和脊髓等解剖結構重要且血管豐富的區域時,需要對組織進行精準處理。對先進腫瘤切除術的持續需求,以及對領先平台提供的骨骼減容和微解剖等功能的關注,將推動市場在預測期內穩步擴張。
在神經外科核心領域,超音波吸引器市場在系統層面已趨於成熟。幾乎所有進行神經外科手術的醫療機構都已採用超音波吸引器,而老舊系統的更換是醫療設備銷售的最大驅動力。典型的5-7年更換週期為製造商提供了可預測且永續的收入基礎,但也限制了在現有神經基本客群中擴大系統應用的機會。這一趨勢表明,該市場資本設備成長受到結構性限制,創新和商業性重心正日益轉向更廣泛的適應症和一次性產品領域。
神經外科以外的應用是推動新系統普及的最重要機會來源。超音波吸引器可用於肝臟、腎臟和脾臟腫瘤切除,以及其他血管豐富的器官手術,其潛在價值已在包括普通外科、婦科、循環系統、消化內科和整形外科在內的多個專科領域得到認可。這種向鄰近專科的拓展正在推動醫院各科室的普及,尤其是在一次性吸頭市場。日益多樣化的軟組織和骨骼手術的專用吸頭設計,也促進了每個系統耗材銷售額的成長。
一次性耗材產品(包括探針尖端、導管和配件)是持續的收入來源,支撐著僅靠設備安裝無法實現的市場價值成長。隨著系統安裝數量的增加及其應用範圍擴展至多個專科,每個系統每年的耗材消耗量也在上升,對耗材銷售產生協同效應。這在一定程度上抵消了神經外科設備市場近乎完美的滲透率所導致的成長停滯。
更換需求
老舊超音波吸引器的更換是資本設備領域銷售額的最大促進因素。超音波吸引器的典型更換週期約為5至7年,這造就了可預測且持續的需求基礎,從而確保了市場規模不受新設備安裝的影響。隨著全球已安裝系統的老化以及醫療機構升級到性能、精度和整合功能更好的最新一代平台,更換銷售將繼續推動資本設備收入的成長。雖然這種更換趨勢不會增加已安裝系統的總數,但它永續地支撐著製造商的收入,並為升級到價格更高、功能更強大的系統(例如骨修整、高級解剖模式和整合吸引器控制)提供了商機。
擴大適應症範圍
超音波吸引器已在肝臟、腎臟和脾臟等高血管器官的腫瘤切除中確立了臨床效用,其應用範圍正在擴展到一般外科、婦科、循環系統、消化內科和整形外科。臨床應用的拓展正在擴大目標基本客群,使其不再局限於神經外科,推動了顯著成長,尤其是在一次性探頭尖端市場。在該市場中,用於軟組織和骨科手術的專用探頭尖端正不斷開發,以滿足各專科的特定應用需求。隨著這些鄰近專科對超音波吸引技術的臨床理解不斷加深,新系統及其相關耗材的採用率預計將會提高。
市場飽和
超音波吸引器市場已趨於成熟,其主要客戶群—神經外科領域的市場已高度飽和。這嚴重限制了新系統進入成熟市場的潛力。由於幾乎所有進行神經外科手術的機構都已配備超音波吸引器,因此神經外科領域本質上是一個純粹的更換市場,透過獲取新客戶來提高銷售幾乎沒有意義。此外,與市場發展初期相比,核心產品類型的技術進步速度已顯著放緩,導致產品主導升級週期的步伐減慢,並限制了因功能增加而帶來的平均售價(ASP)成長。因此,該市場的商業性可行性主要取決於現有設備的更換週期、向神經外科以外的鄰近專科領域的拓展以及耗材和配件市場的成長,而非核心資本設備滲透率的成長。
The global ultrasonic aspirator market was valued at approximately $440 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.5%, reaching approximately $557 million by 2032.
This report covers capital equipment, disposable probe tips, disposable tubing, handpieces, and accessories across the global ultrasonic aspirator market. The report quantifies procedure numbers, unit sales, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
Tumor removal is a primary driver of the ultrasonic aspirator market, as these devices enable selective targeting of cancerous tissue while preserving surrounding nerves and blood vessels. This capability makes them particularly valuable in complex neurosurgical and highly vascular anatomical settings. Market growth is supported by a steady replacement cycle of approximately five to seven years for capital equipment, and by expanding clinical adoption in non-neurosurgical specialties where ultrasonic aspiration offers meaningful advantages in dissection of highly vascular organs.
The market is mature and near-saturated in its primary neurosurgical base, with essentially all facilities that perform neurosurgery already equipped with an ultrasonic aspirator. Penetration into adjacent surgical specialties including general surgery, gynecology, gastroenterology, and orthopedics represents the primary avenue for unit volume growth beyond the replacement cycle, with the disposable tip segment particularly active as specialized tip designs for diverse applications are developed and adopted.
Market Overview
Ultrasonic aspirators use high-frequency vibration to selectively fragment and aspirate tissue, enabling surgeons to remove tumor masses and other target tissue with a high degree of precision while minimizing damage to adjacent nerves, blood vessels, and healthy parenchyma. This capability is particularly valuable in neurosurgery, where complex tumor resections in the brain and spinal cord require precise tissue management in anatomically critical and highly vascular regions. Continued demand for advanced tumor removal procedures, along with interest in capabilities such as bone shaving and fine dissection offered by leading platforms, supports steady market expansion across the forecast period.
The market is mature at the system level within its core neurosurgical base. Essentially all facilities that perform neurosurgery are already equipped with an ultrasonic aspirator, making the replacement of aging systems the largest single driver of capital equipment sales. The typical replacement cycle of five to seven years provides a predictable and sustained revenue base for manufacturers, but limits the opportunity for incremental system placements within the existing neurosurgical customer base. This dynamic defines a market where capital equipment growth is structurally constrained and where innovation and commercial focus have increasingly shifted toward expanding indications and the disposable product segments.
Non-neurosurgical applications represent the most meaningful source of new system placement opportunity. Ultrasonic aspirators are applicable to the dissection of tumors in the liver, kidney, and spleen and to procedures in other highly vascular organs, and their potential value has been recognized across specialties including general surgery, gynecology, cardiology, gastroenterology, and orthopedics. This expansion into adjacent specialties is driving broader hospital department adoption and is particularly reflected in the disposable tip market, where a growing variety of specialized tip designs for soft tissue and bone applications is supporting incremental consumable revenue per system.
The disposable product segments, including probe tips, tubing, and accessories, provide a recurring revenue stream that supports market value growth beyond what capital equipment placements alone would generate. As the installed base of systems grows and shifts toward multi-specialty use, the volume of disposables consumed per system per year increases, creating a compounding effect on consumable revenue that partially offsets the growth ceiling imposed by near-full penetration in the neurosurgical capital equipment segment.
Market Drivers
Replacement Business
The replacement of aging ultrasonic aspirator systems is the largest single driver of unit sales in the capital equipment segment. Ultrasonic aspirators have a typical replacement cycle of approximately five to seven years, creating a predictable and recurring demand base that sustains market volume independent of new facility adoption. As the global installed base of systems ages and facilities upgrade to current-generation platforms with improved performance, precision, and integration capabilities, replacement sales will continue to drive capital equipment revenue. While this replacement dynamic does not expand the total number of installed systems, it supports sustained manufacturer revenue and provides commercial opportunities to upgrade customers to higher-priced systems with expanded functionality such as bone shaving, advanced dissection modes, and integrated aspiration controls.
Expanded Indications
Penetration into non-neurosurgical hospital departments represents the primary opportunity for new system placements and incremental unit volume growth beyond the replacement cycle. Ultrasonic aspirators have established clinical utility in the dissection of tumors in highly vascular organs including the liver, kidney, and spleen, and their application is expanding across general surgery, gynecology, cardiology, gastroenterology, and orthopedics. This broadening of the clinical indication base is expanding the addressable customer base beyond neurosurgery departments and is driving particular growth in the disposable probe tip market, where a growing range of specialized tips for soft tissue and bone procedures has been developed to address the unique requirements of each specialty application. As clinical familiarity with ultrasonic aspiration grows across these adjacent specialties, new system placements and associated consumable adoption are expected to increase.
Market Limiters
Market Saturation
The ultrasonic aspirator market is mature and heavily saturated within its primary neurosurgical customer base, which severely limits the potential for new system placements in established markets. Essentially all facilities that perform neurosurgical procedures are already equipped with an ultrasonic aspirator, meaning that the neurosurgical segment is effectively a pure replacement business with no meaningful opportunity for incremental unit growth from new customer acquisition. Technological advancement in the core product category has also slowed considerably compared to earlier periods of market development, reducing the pace of product-driven upgrade cycles and limiting ASP growth from feature premiums. The commercial viability of the market therefore depends primarily on the replacement cycle for existing installations, expansion into adjacent non-neurosurgical specialties, and growth in the consumable and accessories segments rather than on growth in the core capital equipment penetration rate.
Market Coverage and Data Scope
Markets Covered and Segmentation
Competitive Analysis
Stryker was the leading competitor in the ultrasonic aspirator market in 2025, driven by its Sonopet product line offering multiple handpiece and tip configurations for both soft tissue and bone applications. The Sonopet iQ system enhances surgical precision and procedural efficiency through integrated fragmentation, emulsification, and aspiration capabilities, serving neurosurgery, spine, and ENT applications. Stryker's market leadership is supported by its broad neurosurgical commercial presence and its ability to position the Sonopet platform as part of an integrated suite of neurosurgical capital equipment and instruments.
Integra LifeSciences was the second-leading competitor in the ultrasonic aspirator market in 2025, supported by its long-established CUSA platform, which is known for precision and reliability in neurosurgical tissue removal. The CUSA Clarity system enhances performance with advanced tissue removal capabilities and integrated technologies that support adoption in leading academic neurosurgical programs. Integra's heritage in the CUSA brand, combined with ongoing platform development, has sustained its position as the primary alternative to Stryker in the high-acuity neurosurgical segment.
Bioventus was the third-leading competitor in the ultrasonic aspirator market in 2025. The company's Nexus platform combines ultrasonic aspiration, bone cutting, and wound debridement capabilities in an integrated surgical solution, enhancing procedural versatility and efficiency across a range of surgical applications. Bioventus's multi-modality approach differentiates the Nexus platform from single-modality aspirator systems and positions the company to capture adoption in surgical settings where the combination of tissue aspiration and bone management capabilities in a single system provides workflow and economic advantages.
Technology and Practice Trends
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Ultrasonic Aspirator Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail across all five product categories. Use it to quantify demand, benchmark competitors, and plan commercial strategy across a mature capital equipment market where growth depends on replacement cycle management, consumable depth, and disciplined expansion into adjacent surgical specialties.